Such cell surface localisation and the ability to bind and internalise different pathogens, strongly suggest that NCL may also interact with the tumour-associated microbiome, the study of which emerged a few years ago, and whose role in cancer initiation, progression or regression is under discussion [141, 142]. The gene discussed is NUCLEOLIN; the disease is cancer.